Leadership Announcement: Shannon Carpenter, MD

Dr. Shannon Carpenter has accepted the role of Division Director of Hematology, Oncology and Bone Marrow Transplant, effective immediately. Dr. Carpenter earned her undergraduate degree in Biochemistry from the University of Virginia and her medical degree from Virginia Commonwealth University. Following pediatric residency at Cincinnati Children’s Hospital, she completed her pediatric hematology/oncology fellowship at Duke. Prior to joining Children’s Mercy in 2008, Dr. Carpenter was a faculty member at the University of Texas – San Antonio. Dr. Carpenter has been an Associate Division Director in Hematology/Oncology/Bone Marrow Transplant and Section Chief of Hematology since 2013. She stepped into the role of interim Division Director of Heme/Onc/BMT in September 2024.

Dr. Carpenter's clinical and research interests focus on bleeding and clotting disorders. She is the Associate Director of the Kansas City Comprehensive Hemophilia Treatment Center, Director of the Anticoagulation Management Program, and Program Director of the Coagulation Medicine Fellowship at Children’s Mercy Hospital. Dr. Carpenter is a clinical scientist with multiple projects ranging from funded investigator-initiated research to multicenter clinical trials. She has also served as the primary research mentor for numerous residents, fellows, and junior faculty. Dr. Carpenter currently leads a national trial investigating untreated children with hemophilia and is involved in studies of bleeding disorders in women and girls.

Thank you to the members of the search committee for all their efforts on behalf of the DOP and Children’s Mercy: Committee Co-Chairs Drs. Sherwin Chan (Radiology) and Tarak Srivastava (Nephrology), and committee members Drs. Ghufran Babar (Endocrine), Todd Bradley (Genomic Medicine Center), Denise Bratcher (GME), Andrea Carver (Heme/Onc), Aileen Har (Gastroenterology), Tomoo Iwakuma (CMRI), Karen Lewing (Heme/Onc), and Doug Myers (Heme/Onc).